Haplotype Labs

haplotypelabs.com

Haplotype Labs is a startup focused on enhancing human healthspan through innovative SaaS technology in population genetics. Founded in 2024, the company aims to significantly reduce sequencing costs by 50% to 90%, while utilizing polygenic risk models to predict, detect, and prevent diseases. Their approach accelerates timelines by eliminating the need for bespoke software pipelines, positioning them as a leader in the market for accessible and sophisticated genetic analysis tools. Backed by Y Combinator, Haplotype Labs leverages the founder's extensive experience from 23andMe to drive advancements in genetic software and risk assessment.